share_log

Recursion Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

Recursion Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

Recursion Pharmaceuticals | 144：擬議出售證券
美股SEC公告 ·  07/10 04:32
牛牛AI助理已提取核心訊息
Recursion Pharmaceuticals, Inc. officer Secora Michael is set to sell 15,000 Class A shares of the company on 07/09/2024, with an aggregate market value of $109,777.31. The shares were originally acquired on 06/13/2023 through a stock option exercise from the issuer, with a cash payment made on the same date. This planned transaction follows a series of sales over the past three months, where a total of 78,124 shares were sold for gross proceeds of $645,887.34.
Recursion Pharmaceuticals, Inc. officer Secora Michael is set to sell 15,000 Class A shares of the company on 07/09/2024, with an aggregate market value of $109,777.31. The shares were originally acquired on 06/13/2023 through a stock option exercise from the issuer, with a cash payment made on the same date. This planned transaction follows a series of sales over the past three months, where a total of 78,124 shares were sold for gross proceeds of $645,887.34.
Recursion Pharmaceuticals股份有限公司官員Secora Michael計劃於2024年7月9日賣出公司的1.5萬Class A股，市值$109,777.31。這些股票最初是於2023年6月13日從發行人處通過股票期權行權獲得的，當日進行了現金支付。這次計劃中的交易是在過去三個月內一系列銷售行動之後，總共有78124股股票以總收益645,887.34美元的價格出售。
Recursion Pharmaceuticals股份有限公司官員Secora Michael計劃於2024年7月9日賣出公司的1.5萬Class A股，市值$109,777.31。這些股票最初是於2023年6月13日從發行人處通過股票期權行權獲得的，當日進行了現金支付。這次計劃中的交易是在過去三個月內一系列銷售行動之後，總共有78124股股票以總收益645,887.34美元的價格出售。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生，只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。